MT-5547

MT-5547 · Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-5547, covering 2023-05-17 to 2023-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain [Phase 2, Phase 3]

See pricing